Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]

Zhang L, Wang TT, Li Q, et al. Int J Nanomedicine. 2016;11:2663–2673.Following a review of their data post-publication, the authors found errors in the kidney and PPT group image used for Figure 7 on page 2671 and the spleen control and PP group images a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang L, Wang TT, Li Q, Huang J, Xu H, Li J, Wang Y, Liang Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/08631526ab394bd0908cfe78342da9b9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Zhang L, Wang TT, Li Q, et al. Int J Nanomedicine. 2016;11:2663–2673.Following a review of their data post-publication, the authors found errors in the kidney and PPT group image used for Figure 7 on page 2671 and the spleen control and PP group images and liver PP and PPT group images used for Figure 8 on page 2671. For accuracy and experimental integrity these images have been corrected, with no impact to the conclusions of the study. The authors apologize for these errors. Read the original article